Non-cardiac surgery and antiplatelet therapy following coronary artery stenting

被引：17

作者：

Luckie, M. ^{[1
]}

Khattar, R. S. ^{[1
]}

Fraser, D. ^{[1
]}

机构：

[1] Manchester Royal Infirm, Manchester Heart Ctr, Manchester M13 9WL, Lancs, England

来源：

HEART | 2009年 / 95卷 / 16期

关键词：

DRUG-ELUTING STENTS; OPTICAL COHERENCE TOMOGRAPHY; ST-SEGMENT ELEVATION; HIGH-RISK PATIENTS; TASK-FORCE; MYOCARDIAL-INFARCTION; VASCULAR-SURGERY; CARDIAC EVENTS; BARE-METAL; CLOPIDOGREL;

D O I：

10.1136/hrt.2008.161273

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Coronary artery stenting is increasingly used as a treatment for coronary artery disease. A period of antiplatelet therapy is mandatory following coronary stenting, in order to minimise the risk of stent thrombosis. About 5% of patients who undergo coronary stenting will require non-cardiac surgery within 12 months, and the management of antiplatelet therapy in this setting is complex, requiring a balance between the risks of both operative haemorrhage and stent thrombosis. The available evidence to guide decision-making in the management of antiplatelet therapy in this setting is reviewed.

引用

页码：1303 / 1308

页数：6

共 34 条

[11] Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem? [J].

Godet, G. ;

Le Manach, Y. ;

Lesache, F. ;

Perbet, S. ;

Coriat, P. .

BRITISH JOURNAL OF ANAESTHESIA, 2008, 100 (04) :472-477

[12] Prevention of premature ditscontinuation of dual antiplatelet therapy in patients with coronary artery stents [J].

Grines, Cindy L. ;

Bonow, Robert O. ;

Casey, Donald E., Jr. ;

Gardner, Timothy J. ;

Lockhart, Peter B. ;

Moliterno, David J. ;

O'Gara, Patrick ;

Whitlow, Patrick .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (06) :734-739

[13] Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials [J].

Hoffmann, R. ;

Morice, M-C ;

Moses, J. W. ;

Fitzgerald, P. J. ;

Mauri, L. ;

Breithardt, G. ;

Schofer, J. ;

Serruys, P. W. ;

Stoll, H-P ;

Leon, M. B. .

HEART, 2008, 94 (03) :322-328

[14] Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk [J].

Joner, Michael ;

Finn, Aloke V. ;

Farb, Andrew ;

Mont, Erik K. ;

Kolodgie, Frank D. ;

Ladich, Elena ;

Kutys, Robert ;

Skorija, Kristi ;

Gold, Herman K. ;

Virmani, Renu .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :193-202

[15] Catastrophic outcomes of noncardiac surgery soon after coronary stenting [J].

Kaluza, GL ;

Joseph, J ;

Lee, JR ;

Raizner, ME ;

Raizner, AE .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (05) :1288-1294

[16] Stent-related cardiac events after non-cardiac surgery: Drug-eluting stent vs. bare metal stent [J].

Kim, Hack-Lyoung ;

Park, Kyung-Woo ;

Kwak, Jae-Jin ;

Kim, Yong-Seok ;

Sir, Jung-Ju ;

Lee, Sook-Jin ;

Lee, Hae-Young ;

Chang, Hyuk-Jae ;

Kang, Hyun-Jae ;

Cho, Young-Seok ;

Chung, Woo-Young ;

Chae, In-Ho ;

Choi, Dong-Joo ;

Kim, Hyo-Soo ;

Oh, Byung-Hee ;

Park, Young-Bae ;

Koo, Bon-Kwon .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 123 (03) :353-354

[17]

Kunadian Babu, 2006, Interact Cardiovasc Thorac Surg, V5, P630, DOI 10.1510/icvts.2006.140038

[18] Drug eluting stents are safe for licensed indications, says FDA [J].

Mayor, Susan .

BRITISH MEDICAL JOURNAL, 2006, 333 (7581) :1235-1235

[19] Drug-eluting stents: a critique [J].

Melikian, N. ;

Wijns, W. .

HEART, 2008, 94 (02) :145-152

[20]

Newsome L.T., 2006, Anesthesia Patient Safety Foundation Newsletter, V4, P81

← 1 2 3 4 →